Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancer
口腔上皮稳态和癌症中祖细胞更新和分化的功能探索
基本信息
- 批准号:10677648
- 负责人:
- 金额:$ 24.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-02 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationApoptosisBar CodesBindingBioinformaticsBiological AssayCandidate Disease GeneCell CycleCell Cycle ArrestCell Cycle RegulationCell Differentiation processCellsChromosomesClonal ExpansionDataDevelopmentDisadvantagedEpithelial CellsEpitheliumExposure toFoundationsFutureGene Expression ProfileGenesGeneticGenetic ScreeningGenetic TranscriptionGoalsGrowthHead and Neck Squamous Cell CarcinomaHomeostasisHuman papilloma virus infectionInjectionsKnowledgeLentivirusLesionMaintenanceMalignant NeoplasmsMeasuresMediatingMitoticModelingMolecularMusMutateMutationOncogenesOncogenicOralPIK3CA genePIK3CG genePathway interactionsPatientsPatternPhasePlacentaPopulationPublishingResearchResearch PersonnelSignal InductionSignal TransductionStratified EpitheliumStromal CellsTP53 geneTestingTissuesTobacco useTrainingTumor PromotionWorkcancer typecraniofacialepithelial stem cellgenome-wideimprovedin vivoinflammatory milieuinsightknockin animalmaxillofacialmultiple omicsmutantnew therapeutic targetnovelnovel therapeutic interventionoral cavity epitheliumoral tumorigenesispatient prognosispostmitoticprogenitorprogramspromotersenescencestem cell fatestem cell nichestem cellstumortumor initiationtumor microenvironmenttumorigenesis
项目摘要
Project Summary
Head and neck squamous cell carcinoma (HNSCC) is the most common cancer type initiated from stratified
epithelium of oral and maxillofacial region. Despite great effort to characterize HNSCC via high throughput
multi-omics approaches, significant improvements in patient prognosis are yet to be made. This is largely due
to incomplete understanding of how cancer-associated lesions reprogram epithelial cells to expand and
transform, at cellular and molecular levels. Stratified epithelium is a tissue characterized by (a) highly
proliferative basal progenitor cells, (b) progenitor differentiation which is accompanied by complete loss of
mitotic potential, and (c) stem cell fate choice between the proliferative progenitor and differentiated postmitotic
states. As such, growth rate of stratified epithelia is controlled by balancing rates of renewal and differentiation.
In my recently published work, I found that oncogenic activation of Pik3ca, the most commonly mutated
oncogene in HNSCC, results in growth disadvantage in stratified epithelia. Using direct measure of cell fate
choice in vivo, I found that oncogenic PI3K signaling induces differentiation. This serves to counterbalance
accelerated cell cycle independently of senescence or apoptosis, and acts as a dominant cellular mechanism
to restrict clonal expansion. Building on that study, my current proposal will test the hypothesis that genetic
lesions and niche factors found in PI3K mutant HNSCC promote tumorigenesis by overcoming oncogene-
induced differentiation. In my preliminary work I used multiple rounds of genetic screens in vivo to identify
renewal promoters among ~500 patient-derived lesions associated with PIK3CA mutations. Through this large-
scale effort I identified the minimal combination of lesions required to overcome PI3K induced differentiation
and initiate HNSCC formation. Among these lesions, loss of Trp53 acts as a primary renewal promoter. Using
a canonical p53 function deficient Trp533KR/3KR knock-in animal, I found that Trp53 loss drives HNSCC by
promoting renewal, and independent of cell cycle arrest, senescence and apoptosis. By comparing
chromosome accessibility between WT, Trp533KR/3KR and Trp53-/- epithelium I found that p53 can
transcriptionally suppress key renewal genes, and I propose to study the importance of these genes for p53-
mediated progenitor differentiation. In parallel, I identified secretory factors specifically expressed in HNSCC
progenitor niche. I used a genetic screen to test their potential to overcome PI3K induced differentiation. With a
novel intra-placenta lentivirus injection strategy, I am able to infect a spectrum of stromal cells present in niche
of stratified epithelium. Thus, I will functional test key pro-renewal factors in stromal cells during HNSCC
initiation to uncover the underlying molecular pathways mediating epithelial renewal. In summary, my
preliminary data identify key genetic lesions and secreted niche factors that may drive HNSCC formation by
overcoming PI3K induced differentiation. My proposal will continue to test this model, with the ultimate goal of
uncovering molecular mechanism of how PI3K induced differentiation barrier is breached in HNSCCs.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHE YING其他文献
ZHE YING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHE YING', 18)}}的其他基金
Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancer
口腔上皮稳态和癌症中祖细胞更新和分化的功能探索
- 批准号:
10475404 - 财政年份:2021
- 资助金额:
$ 24.56万 - 项目类别:
Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancer
口腔上皮稳态和癌症中祖细胞更新和分化的功能探索
- 批准号:
10004026 - 财政年份:2019
- 资助金额:
$ 24.56万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




